J. Jay Lobell's most recent trade in Fortress Biotech Inc was a trade of 49,383 common stock, par value $0.001 done . Disclosure was reported to the exchange on Jan. 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Fortress Biotech Inc | J. Jay Lobell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 49,383 | 165,075 (0%) | 0% | 0 | common stock, par value $0.001 | |
| Fortress Biotech Inc | J. Jay Lobell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 6,666 | 115,692 (0%) | 0% | 0 | COMMON STOCK, PAR VALUE $0.001 | |
| Fortress Biotech Inc | J. Jay Lobell | Director | Purchase of securities on an exchange or from another person at price $ 0.84 per share. | 10 Feb 2023 | 299,401 | 1,635,401 (2%) | 0% | 0.8 | 250,000 | COMMON STOCK, PAR VALUE $0.001 |
| Fortress Biotech Inc | J. Jay Lobell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2023 | 100,000 | 1,336,000 (1%) | 0% | 0 | COMMON STOCK, PAR VALUE $0.001 | |
| Fortress Biotech Inc | J. Jay Lobell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 100,000 | 1,236,000 (1%) | 0% | 0 | Common Stock, par value $0.001 |